ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Vision blurred | 17.17.01.010; 06.02.06.007 | 0.002931% | | |
Visual acuity reduced | 17.17.01.011; 06.02.03.001 | 0.000533% | | |
Visual impairment | 06.02.06.008 | 0.002398% | | Not Available |
Vomiting | 07.01.07.003 | 0.019182% | | |
Weight decreased | 13.15.01.005 | - | - | |
Weight increased | 13.15.01.006 | - | - | |
Wheezing | 22.03.01.009 | - | - | |
White blood cell count decreased | 13.01.06.012 | 0.005595% | | |
Cardiotoxicity | 12.03.01.007; 02.01.01.002 | 0.000533% | | Not Available |
Hypoacusis | 04.02.01.006 | 0.000799% | | |
Peripheral swelling | 08.01.03.053; 02.05.04.015 | 0.009324% | | Not Available |
Balance disorder | 17.02.02.007 | 0.003197% | | Not Available |
Contusion | 24.07.06.001; 23.03.11.002; 15.03.01.008; 12.01.06.001 | - | - | |
Musculoskeletal chest pain | 22.09.01.001; 15.03.04.012 | 0.000799% | | |
Malignant neoplasm progression | 16.16.01.005 | - | - | Not Available |
Oesophageal rupture | 12.01.09.012; 07.04.05.005 | 0.000533% | | Not Available |
Haemorrhage | 24.07.01.002 | - | - | Not Available |
Hypoaesthesia oral | 17.02.06.021; 07.05.05.003 | 0.000533% | | Not Available |
Cognitive disorder | 17.03.03.003; 19.21.02.001 | - | - | |
Gastrointestinal toxicity | 07.08.03.006; 12.03.01.019 | - | - | Not Available |
Hepatic enzyme increased | 13.03.01.019 | - | - | Not Available |
Hot flush | 24.03.01.005; 21.02.02.001; 08.01.03.027 | - | - | |
Cardiac disorder | 02.01.01.003 | - | - | Not Available |
Feeding disorder | 19.09.01.003; 14.03.02.003 | 0.000533% | | Not Available |
Limb discomfort | 15.03.04.014 | 0.000533% | | Not Available |
Lung infection | 22.07.01.008; 11.01.09.008 | 0.001066% | | |
Partial seizures | 17.12.03.010 | 0.000533% | | Not Available |
Upper limb fracture | 15.08.03.018; 12.04.01.018 | 0.000533% | | Not Available |
Decreased appetite | 14.03.01.005; 08.01.09.028 | - | - | |
Ill-defined disorder | 08.01.03.049 | 0.000533% | | Not Available |